G
Galmed Pharmaceuticals Ltd. (GLMD)
NCM – Real Time Price. Currency in USD
0.58
+0.00 (0.79%)
At close: May 12, 2026, 4:00 PM EDT
0.59
+0.01 (1.49%)
After-hours: May 12, 2026, 7:44 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.58
+0.00 (0.79%)
At close: May 12, 2026, 4:00 PM EDT
0.59
+0.01 (1.49%)
After-hours: May 12, 2026, 7:44 PM EDT
Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications. The company develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in a Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through the ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company is developing MyBiotics, which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.
| Name | Position |
|---|---|
| Dr. Liat Hayardeny MBA, Ph.D. | Chief Scientific Officer |
| Dr. Tali Gorfine | Medical Consultant |
| Mr. Allen Baharaff | Co-Founder, President, CEO & Chairman |
| Mr. Doron Cohen | Chief Financial Officer |
| Mr. Guy Nehemya | COO & Data Protection Officer |
| Mr. Yohai Stenzler CPA | Chief Accounting Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-06 | 6-K | form6-k.htm |
| 2026-04-14 | 6-K | form6-k.htm |
| 2026-04-09 | 6-K | form6-k.htm |
| 2026-03-31 | POS AM | formposam.htm |
| 2026-03-05 | 6-K | form6-k.htm |
| 2026-03-04 | 6-K | form6-k.htm |
| 2026-02-09 | 6-K | form6-k.htm |
| 2026-01-30 | 6-K | form6-k.htm |
| 2025-12-08 | 6-K | form6-k.htm |
| 2025-12-04 | 6-K | form6-k.htm |